Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Monza
Clinical trial register · Italy

Clinical Trials in Monza, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 2843 Bologna 1305 Roma 1274 Naples 984 Rome 967
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
University of Milano Bicocca23 AstraZeneca21 Merck Sharp & Dohme LLC13 Janssen Research & Development, LLC9 Eli Lilly and Company9
Site location
Milan2843 Bologna1305 Roma1274 Naples984 Rome967
All 489 locations
Target enrolment
to

Trials with a site in Monza

277 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
Endoscopic Management of Biliopancreatic Disease in the Lombardy Pancreas Units
NCT07418164Pancreatic Cancer, Biliopancreatic Diseases, Periampullary Neoplasms
IRCCS San Raffaele
Observational
2,500
Bergamo, Brescia, Cremona, Legnano, Mantua, Milan, Monza, Pavia
2026-10-31
Recruiting
Daiichi Sankyo
Phase 1/2
220
Aviano, Meldola, Milan, Monza, Padova, Pisa
2026-09-17
Recruiting
Boehringer Ingelheim
Phase 3
466
Catania, Foggia, Forlì, Milan, Monza, Padova, Roma
2026-09-17
Recruiting
Newronika
Not applicable
104
Monza
2026-08-26
Recruiting
[68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
NCT07702292Colorectal Cancer, Epithelial Ovarian Cancer, Gastric Cancer (GC), Pancreatic Ductal Adenocarcinoma (PDAC)
Blue Earth Diagnostics
Phase 2
71
Bergamo, Monza, Roma, Milan
2026-06-30
Recruiting
Chiesi Italia
Observational
75
Arezzo, Bari, Bologna, Caserta, Monza, Naples, Palermo
2026-06-15
Recruiting
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
NCT07652658Idiopathic Pulmonary Fibrosis (IPF)
AstraZeneca
Phase 2
359
Foggia, Forlì, Modena, Monza, Pavia, Rozzano, Siena, Torino
2026-06-11
Recruiting
University of Milano Bicocca
Phase 2
122
Monza
2026-06-03
Not yet open
Safety of Bronchoscopy in Patients With Interstitial Lung Disease
NCT07627594Interstitial Lung Disease (ILD), Bronchoscopy, Bronchoalveolar Lavage (BAL), Acute Exacerbation
University of Milan
Observational
427
Milan, Bologna, Genova, Legnano, Modena, Monza, Naples, Siena
2026-06-01
Not yet open
Fondazione IRCCS San Gerardo dei Tintori
Not applicable
100
Monza
2026-06
Recruiting
Incyte Corporation
Phase 2
60
Bologna, Genova, Monza, Padua, Pavia, Rome
2026-05-20
Recruiting
Ipsen
Phase 3
350
Genova, Milan, Modena, Monza, Novara, Padova, Roma, Rozzano
2026-05-14
Recruiting
Eli Lilly and Company
Phase 2
60
Florence, Milan, Monza, Negrar, Roma, Rozzano
2026-05-04
Recruiting
Eli Lilly and Company
Phase 2
60
Florence, Milan, Monza, Negrar, Roma, Rozzano
2026-05-04
Recruiting
Inhibikase Therapeutics
Phase 3
486
Monza
2026-04-23
Recruiting
Gruppo Oncologico Italiano di Ricerca Clinica
Observational
100
Bari, Bergamo, Bologna, Misterbianco, Monza, Milan, Modena, Padova
2026-04-14
Recruiting
Eli Lilly and Company
Phase 4
150
Alessandria, Florence, Messina, Monza, Perugia, Rome, Terni
2026-03-09
Recruiting
Lombard Cohort of Brain Health Services
NCT07457138Subjective Cognitive Decline (SCD), Functional Cognitive Disorder, Alzheimer's Disease, Brain Health
University of Milano Bicocca
Observational
1,000
Costa Masnaga, Milan, Monza, San Donato Milanese
2026-02-01
Recruiting
ABlative Radiotherapy (for) Unfavorable Prostate Tumors 2.0
NCT07407608Prostate Cancer, Prostate Cancer (Adenocarcinoma), Prostate Cancer Non-Metastatic
University of Milano Bicocca
Observational
58
Monza
2026-01-28
Recruiting
CSL Behring
Phase 2
84
Brindisi, Milan, Modena, Monza, Naples, Verona
2026-01-22
Recruiting
Insmed Incorporated
Phase 3
344
Bologna, Catania, Milan, Modena, Monza, Naples, Pavia, Roma
2026-01-07
Recruiting
Eli Lilly and Company
Phase 3
800
Bergamo, Bologna, Florence, Genova, Meldola, Milan, Misterbianco, Monza
2025-12-22
Recruiting
ALX Oncology Inc.
Phase 2
120
Torrette, Genova, Bergamo, Bologna, Milan, Monza, Novara
2025-12-10
Recruiting
AbbVie
Phase 2/3
490
Milan, Monza, Fano, Aviano, Rome, Candiolo, Catania, Verona
2025-12-10
Recruiting
Sanofi
Phase 2
37
Rome, Turin, Monza
2025-12-02
Recruiting
Multidomain Intervention Based on ICOPE
NCT07829120Intrinsic Capacity
University of Milano Bicocca
Not applicable
250
Monza
2025-12-01
Recruiting
Eli Lilly and Company
Phase 3
7,140
Bologna, Brescia, Ferrara, Florence, Genova, Milan, Monza, Palermo
2025-12-01
Recruiting
Genmab
Phase 3
660
Bologna, Meldola, Monza, Milan, Prato, Reggio Emilia
2025-11-28
Recruiting
Syndax Pharmaceuticals
Phase 3
468
Monza, Pesaro, Alessandria, Bergamo, Bologna, Brescia, Candiolo, Florence
2025-11-25
Active, closed
Art of Memory for Cognitive Enhancement in the Monza Brain Health Service
NCT07479914Subjective Cognitive Decline (SCD), Alzheimer's Disease, Cognitive Enhancement
University of Milano Bicocca
Not applicable
80
Monza
2025-11-24
Recruiting
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
NCT07085767Breast Cancer, Locally Advanced Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer
DrugsPalazestrant·Ribociclib·Letrozole
Olema Pharmaceuticals, Inc.
Phase 3
1,000
Naples, Bologna, Aviano, Rome, Genoa, Bergamo, Milan, Monza
2025-11-03
Recruiting
AstraZeneca
Phase 3
400
Milan, Monza, Orbassano, Padova, Rozzano
2025-10-31
Recruiting
BioNTech SE
Phase 3
558
Aviano, Lucca, Milan, Monza, Pisa, Roma, Torrette
2025-10-30
Recruiting
A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)
NCT07194850Immune Thrombocytopenia (ITP), ITP - Immune Thrombocytopenia, ITP, Immune Thrombocytopenic Purpura
DrugEfgartigimod
argenx
Phase 2/3
24
Genoa, Monza, Roma, Torino
2025-10-20
Recruiting
Centro di Riferimento Oncologico - Aviano
Observational
1,000,000
Altamura, Ancona, Arezzo, Belluno, Florence, Milan, Modena, Monza
2025-10-08
Recruiting
Janssen Research & Development, LLC
Phase 2/3
1,092
Cagliari, Milan, Monza, Negrar-Verona, Roma, Rozzano, Torino
2025-10-03
Recruiting
HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
NCT05745714Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory
DrugsRuxolitinib·Cytarabine·Venetoclax·Dexamethasone
Princess Maxima Center for Pediatric Oncology
Phase 1/2
26
Genova, Monza, Padova, Roma, Turin
2025-10-01
Recruiting
HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
NCT05751044Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory
DrugsDasatinib·Cytarabine·Venetoclax·Dexamethasone
Princess Maxima Center for Pediatric Oncology
Phase 1/2
26
Genova, Monza, Padova, Roma, Turin
2025-10-01
Recruiting
Jazz Pharmaceuticals
Phase 2
125
Milan, Bologna, Genoa, Misterbianco, Monza
2025-09-24
Recruiting
Bristol-Myers Squibb
Phase 2
182
Naples, Monza, Milan, Padova, Bologna
2025-09-09
Not yet open
Fondazione IRCCS San Gerardo dei Tintori
Not applicable
106
Brescia, Monza, Bergamo, Como, Genova, Milan, Padova, Parma
2025-09-01
Not yet open
Rebozo and Maternal Procedures to Reduce Persistent Occiput Posterior Position of the Fetal Head
NCT06887634Persistent Occiput Posterior Position During Labor
University of Milano Bicocca
Not applicable
578
Monza
2025-09
Recruiting
Takeda
Phase 3
150
Naples, Rome, Catania, Bologna, Milan, Monza, Novara, Torino
2025-08-14
Recruiting
Gruppo Oncologico Italiano di Ricerca Clinica
Observational
50
Bari, Meldola, Ferrara, Genova, Lido di Camaiore, Lucca, Monza, Milan
2025-08-12
Recruiting
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
NCT06765109Non-small Cell Lung Cancer, Anaplastic Lymphoma Kinase-positive
DrugsNeladalkib·Alectinib
Nuvalent Inc.
Phase 3
450
Ancona, Bari, Meldola, Milan, Monza, Pisa, Ravenna, Roma
2025-07-17
Recruiting
AbbVie
Observational
250
Castellana Grotte, Monserrato, San Giovanni Rotondo, Rozzano, Milan, Monza, Naples, Turin
2025-07-14
Recruiting
Bristol-Myers Squibb
Phase 3
586
Milan, Monza, Brescia
2025-07-14
Recruiting
MedSIR
Phase 2
200
Ancona, Aviano, Florence, Genova, Milan, Modena, Monza, Naples
2025-06-30
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
NCT06966700Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms
DrugsEpirubicin·Adriamycin·Xeloda·Sacituzumab tirumotecan
Merck Sharp & Dohme LLC
Phase 3
2,400
Monza, Livorno, Ancona, Bergamo, Genova, Milan, Pisa, Reggio Emilia
2025-06-30
Recruiting
AstraZeneca
Phase 2
987
Busto Arsizio, Cuneo, Ferrara, Milan, Monza, Naples, Pavia, Roma
2025-06-27
Recruiting
University of Padova
Observational
100
Mercogliano, Brescia, Rho, Monza, Naples, Ragusa, Cotignola, Sassari
2025-06-20
Recruiting
Readmission and Dehydration Prevention in Patients With Elective Ileostomy
NCT06824623Ileostomy - Stoma, Colorectal Surgery, Dehydration
Multidisciplinary Italian Study group for STOmas (MISSTO)
Observational
300
Legnano, Milan, Monza, Palermo, Rovigo, Sesto San Giovanni, Bologna
2025-06-01
Recruiting
Burden of Cytomegalovirus Reactivation in Pediatric Patients After Allogeneic Hematopoietic Stem Cell Transplantation
NCT06916195Cytomegalovirus Infection, Hematopoietic Stem Cells Transplantation
MSD Italia S.r.l.
Observational
230
Genova, Monza, Padova, Roma, Torino
2025-05-09
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
NCT06881784NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer, NSCLC, NSCLC (Non-small Cell Lung Carcinoma)
DrugsCetuximab·Docetaxel
Revolution Medicines, Inc.
Phase 3
590
Milan, Rossano, Monza, Naples, Pisa, Roma, Rome
2025-05-06
Active, closed
FARAPULSE Workflow Assessment Registry
NCT06656884Atrial Fibrillation (AF)
Boston Scientific Corporation
Observational
524
Ferrara, Mestre, Monza, Rivoli, Vicenza
2025-05-06
Recruiting
University of Milano Bicocca
Observational
50
Monza
2025-05-02
Recruiting
University of Milano Bicocca
Observational
2,000
Monza
2025-04-17
Recruiting
AstraZeneca
Phase 3
600
Catania, Florence, Milan, Monza, Naples, Reggio Emilia, Roma, Rome
2025-03-27
Recruiting
Eli Lilly and Company
Phase 3
700
Bari, Catania, Genova, Meldola, Milan, Monza, Naples, Orbassano
2025-03-27
Recruiting
Daiichi Sankyo
Phase 3
582
Bari, Bologna, Catania, Milan, Monza, Naples, Pisa, Ponderano
2025-03-19
Recruiting
Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia
NCT06376162Relapsed/Refractory KMT2A-r Acute Leukemia, Relapsed/Refractory NUP98-r Acute Leukemia, Relapsed/Refractory NPM1-m Acute Leukemia
DrugsZiftomenib·Cytarabine·Fludarabine
PedAL BCU, LLC
Phase 1
20
Roma, Monza
2025-03-18
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
150
Pavia, Brescia, Milan, Monza
2025-03-06
Recruiting
European Institute of Oncology
Phase 2
45
Monza, Roma, Brindisi, Milan
2025-03-06
Recruiting
University of Milano Bicocca
Phase 2
118
Avezzano, Florence, Messina, Monza, Roma, Udine
2025-03-01
Recruiting
Takeda
Phase 3
171
Naples, Rome, Catania, Bologna, Milan, Monza, Novara, Torino
2025-02-27
Recruiting
Novo Nordisk A/S
Phase 3
510
Orbassano, Verona, Brescia, Catania, Modena, Monza, Naples, Padova
2025-02-17
Recruiting
Study on Plasmablastic Lymphoma Patients
NCT06781359Plasmablastic Lymphoma
Fondazione Italiana Linfomi - ETS
Observational
200
Aviano, Ascoli Piceno, Brescia, Cuneo, Florence, Milan, Monza, Novara
2025-02-14
Recruiting
Dianthus Therapeutics
Phase 3
256
Bergamo, Bologna, Genova, Gussago, Milan, Modena, Monza, Pavia
2025-02-10
Recruiting
BioNTech SE
Phase 3
621
Avellino, Aviano, Cremona, Lucca, Meldola, Monza, Naples, Peschiera del Garda
2025-02-03
Recruiting
Università Vita-Salute San Raffaele
Not applicable
400
Catanzaro, Florence, Genova, Milan, Monza, Naples, Padova, Udine
2025-01-30
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,046
Monza, Rionero in Vulture, Palermo, Candiolo, Ancona, Brescia, Milan, Novara
2025-01-27
Recruiting
Sanofi
Phase 2
84
Florence, Naples, Brescia, Monza
2024-12-19
Active, closed
Phase 2 Study of Rapcabtagene Autoleucel in Myositis
NCT06665256Idiopathic Inflammatory Myopathies
DrugRapcabtagene autoleucel
Novartis Pharmaceuticals
Phase 2
21
Ancona, Brescia, Monza, Milan, Rozzano, Verona
2024-12-17
Active, closed
Vicore Pharma AB
Phase 2
378
Ancona, Bergamo, Monza, Roma, Turin
2024-12-09
Recruiting
Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.
NCT06382948Advanced Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer, ESR1 Gene Mutation
DrugsElacestrant·Everolimus
MedSIR
Phase 3
300
Bergamo, Cagliari, Florence, Genova, Livorno, Milan, Modena, Monza
2024-12-05
Recruiting
Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study
NCT06689956FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma, Stage IA1 Endometrial Cancer FIGO 2023, Stage IA2 Endometrial Cancer FIGO 2023
Mayo Clinic
Observational
212
Verduno, Monza, Milan, Roma, Udine, Naples
2024-12-04
Not yet open
University of Milano Bicocca
Observational
480
Monza
2024-12-01
Recruiting
University of Milano Bicocca
Not applicable
288
Monza
2024-12-01
Recruiting
AstraZeneca
Phase 3
1,160
Florence, Legnano, Livorno, Monza, Peschiera del Garda, Rome
2024-11-27
Active, closed
Genmab
Phase 3
191
Monza, Rozzano, Naples, Aviano, Rome, Orbassano, Bergamo, Candiolo
2024-11-25
Recruiting
AstraZeneca
Phase 3
1,160
Florence, Legnano, Livorno, Monza, Orbassano, Padova, Peschiera del Garda, Roma
2024-11-18
Recruiting
Functional Capacity in Anderson-Fabry Disease Patients
NCT06884358Anderson-Fabry Disease
IRCCS Policlinico S. Donato
Observational
100
Brescia, Milan, San Donato Milanese, Monza, Turin
2024-11-13
Recruiting
Hospital Universitario 12 de Octubre
Not applicable
440
Pozzilli, Acerra, Brescia, Latina, Maddaloni, Monza, Naples, Padova
2024-11-01
Recruiting
Novartis Pharmaceuticals
Phase 1/2
232
Foggia, Monza, Palermo, Pavia, Roma, Sassari, Ivrea, Trieste
2024-10-24
Recruiting
Trauma Molecular Processes
NCT07683169Traumatic Brain Injury
Mario Negri Institute for Pharmacological Research
Observational
500
Bergamo, Monza
2024-10-18
Recruiting
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Observational
617
Alessandria, Bergamo, Bologna, Catania, Florence, Milan, Monza, Naples
2024-10-14
Recruiting
Bristol-Myers Squibb
Phase 3
1,000
Bari, Ravenna, Monza, Milan, Naples, Rome, Peschiera del Garda, Bergamo
2024-10-07
Recruiting
AstraZeneca
Phase 3
744
Bari, Milan, Misterbianco, Monza, Naples, Orbassano, Padova, Parma
2024-10-04
Recruiting
SoniVie Inc.
Not applicable
261
Mercogliano, Monza, Roma
2024-10-03
Recruiting
Stemline Therapeutics, Inc.
Phase 3
4,220
San Giovanni Rotondo, Monserrato, Viagrande, Bologna, Meldola, Monza, Frattamaggiore, Aviano
2024-09-27
Recruiting
Consorzio Oncotech
Observational
300
Bari, Bologna, Cuneo, Catania, Meldola, Florence, Genova, Monza
2024-09-13
Recruiting
A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis
NCT06559150Non-cystic Fibrosis Bronchiectasis
Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA
Phase 2
284
Bologna, Monza, Rozzano, Pavia, Catania
2024-09-11
Active, closed
Pierre Fabre Medicament
Observational
368
Monza
2024-09-10
Recruiting
Jazz Pharmaceuticals
Phase 3
550
Aviano, Bergamo, Bologna, Milan, Modena, Monza, Padova, Pavia
2024-08-13
Recruiting
Janssen Research & Development, LLC
Phase 3
752
Brescia, Catania, Chieti, Genova, Monza, Pisa, Roma, Salerno
2024-07-25
Active, closed
Merck Sharp & Dohme LLC
Phase 3
686
Bologna, Milan, Monza, Rozzano, Turin, Brescia, Catania, Naples
2024-07-24
Recruiting
University of Milano Bicocca
Not applicable
1,340
Monza
2024-07-16
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,530
Naples, Misterbianco, Meldola (FC), Aviano, Rome, Brescia, Milan, Monza
2024-06-24
Recruiting
Clinical Management and Outcomes of Primary Ovarian Leiomyosarcoma
NCT06749600Primary Ovarian Leiomyosarcoma
Azienda USL Reggio Emilia - IRCCS
Observational
30
Modena, Parma, Reggio Emilia, Avellino, Catania, Milan, Monza, Naples
2024-06-14
Recruiting
Merck Sharp & Dohme LLC
Phase 3
851
Naples, Rome, Milan, Monza, Rozzano, Brescia, Genova, Novara
2024-06-10
Recruiting
X4 Pharmaceuticals
Phase 3
176
Torrette, Brescia, Genova, Meldola, Monza, Roma, Torino
2024-06-06
Active, closed
ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer
NCT06328738HER2-positive Breast Cancer, HER2-positive Gastric Cancer, HER2 Positive Solid Tumors, HER2 Amplification
DrugsELVN-002·Eribulin·Leucovorin·Trastuzumab
Enliven Therapeutics
Phase 1
275
Catanzaro, Milan, Monza, Pisa, Reggio Emilia, Rome
2024-05-30
Recruiting
Daiichi Sankyo
Phase 3
540
Bari, Bergamo, Brescia, Catania, Catanzaro, Genova, Milan, Monza
2024-05-21
Recruiting
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
NCT06237452Clostridium Difficile, Clostridium Difficile Infections, Clostridium Difficile Infection Recurrence, Clostridioides Difficile Infection
Vedanta Biosciences, Inc.
Phase 3
852
Alessandria, Lecco, Milan, Monza, Naples, Pavia, Modena, Roma
2024-05-20
Active, closed
Boehringer Ingelheim
Phase 3
1,666
Brescia, Catania, Florence, Foggia, Forlì, Milan, Modena, Monza
2024-05-06
By invitation
Travere Therapeutics, Inc.
Phase 3
100
Bari, Genova, Milan, Monza, Padova
2024-04-30
Recruiting
AstraZeneca
Phase 3
582
Milan, Monza, Orbassano, Padova, Parma
2024-04-29
Recruiting
Integrated Approach in Frail Older People with Atrial Fibrillation
NCT06775028Atrial Fibrillation (AF), Hypertension, Coronary Arterial Disease (CAD), Heart Failure
Heart Care Foundation
Not applicable
1,250
Caserta, Florence, Genova, Grosseto, Monza, Milan, Piacenza, Gubbio
2024-04-11
Recruiting
AstraZeneca
Phase 3
675
Bergamo, Genoa, Milan, Monza, Padova, Pavia, Ravenna, Roma
2024-04-11
Recruiting
Merck Sharp & Dohme LLC
Phase 3
780
Misterbianco, Meldola, Milan, Monza, Rome, Florence, Bergamo, Genova
2024-04-03
Recruiting
Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 1/2
180
Bologna, Milan, Monza
2024-03-26
Active, closed
Gilead Sciences
Phase 3
577
Brescia, Foggia, Milan, Monza, Pavia, Roma
2024-03-25
Recruiting
Centro di Riferimento Oncologico - Aviano
Phase 2
45
Aviano, Florence, Lido di Camaiore, Meldola, Monza, Padova, Parma, Perugia
2024-03-15
Recruiting
University of Milano Bicocca
Observational
300
San Donato Milanese, Monza
2024-03-01
Recruiting
Daiichi Sankyo
Phase 2/3
860
Aviano, Bologna, Catania, Florence, Milan, Monza, Naples, Roma
2024-02-27
Active, closed
First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer
NCT06239467Advanced Cancer, Breast Cancer, Advanced Solid Tumors, PI3K Gene Mutation
DrugsAtirmociclib·Tucatinib·Ribociclib·Fulvestrant
OnKure, Inc.
Phase 1
200
Milan, Monza, Rozzano
2024-02-26
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
762
Meldola (Fc), Milan, Monza, Genova, Brescia, Roma, Ancona, Aviano (PN)
2024-02-21
Active, closed
AbbVie
Observational
1,200
Monserrato, San Giovanni Rotondo, Rozzano, Milan, Monza, Rome, Turin, Palermo
2024-02-19
Recruiting
"Fetal gRowth AbnorMality dEtection Trial"
NCT05043753Small for Gestational Age Infant, Large for Gestational Age Infant, Oligohydramnios, Polyhydramnios
University of Modena and Reggio Emilia
Not applicable
1,566
Modena, Cesena, Monza
2024-01-20
Recruiting
University of Turin, Italy
Observational
10,500
Monza, Orbassano, Torino, Milan, Trento
2024-01-15
Recruiting
Policlinico di Monza SpA
Not applicable
436
Monza
2024-01-12
Recruiting
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
NCT06137118B-cell Acute Lymphoblastic Leukemia (B-ALL)
DrugSurovatamig
AstraZeneca
Phase 1/2
255
Bergamo, Bologna, Monza, Naples, Roma
2023-12-29
Recruiting
Travere Therapeutics, Inc.
Phase 3
70
Bari, Genova, Milan, Monza, Padova
2023-12-28
Recruiting
Regeneron Pharmaceuticals
Phase 3
580
Meldola, Genoa, Monza, Turin, Aviano, Candiolo, Bologna, Brescia
2023-12-28
Active, closed
Bristol-Myers Squibb
Phase 3
190
Aviano, Milan, Monza, Naples, Rome
2023-12-21
Active, closed
Sanofi
Phase 3
1,655
Cona, Florence, Genoa, Milan, Monza, Naples, Rome, Orbassano
2023-12-13
Recruiting
Regeneron Pharmaceuticals
Phase 3
904
Meldola, Monza, Turin, Milan, Modena, Naples, Novara, Pavia
2023-12-13
Active, closed
Syndax Pharmaceuticals
Phase 2
145
Foggia, Milan, Monza, Torino, Padova, Siena, Catania, Florence
2023-12-11
Recruiting
HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies
NCT05658640Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory
DrugsTrametinib·Cytarabine·Dexamethasone·Cyclophosphamide
Princess Maxima Center for Pediatric Oncology
Phase 1/2
26
Genova, Monza, Padova, Roma, Turin
2023-11-14
Recruiting
Intracranial PrEssure Time dOse (ImPETO)
NCT04459806Intracranial Hypertension, Traumatic Brain Injury, Subarachnoid Hemorrhage, Intracranial Hemorrhages
University of Milano Bicocca
Observational
250
Monza
2023-11-13
Active, closed
medac GmbH
Phase 2
49
Bologna, Monza, Pavia, Rome, Turin
2023-11-13
Active, closed
AstraZeneca
Phase 3
863
Alessandria, Bari, Bergamo, Milan, Monza, Orbassano, Padova, Parma
2023-11-09
Recruiting
United Therapeutics
Phase 3
698
Catania, Forlì, Modena, Monza, Roma, Siena, Verona
2023-10-30
Recruiting
Summit Therapeutics
Phase 3
1,600
Ancona, Aviano, Cremona, Genova, Lucca, Mantua, Milan, Monza
2023-10-26
Recruiting
Rescue Stenting and Intravenous Thrombolysis In Patients With Large Vessel Ischemic Stroke
NCT06727006Large Vessel Occlusion, Stroke Acute, Thrombolysis, Rescue Stenting
ASST Santi Paolo e Carlo
Observational
400
Bergamo, Cesena, Lecce, Milan, Monza, Pietra Ligure
2023-10-21
Active, closed
Merck Sharp & Dohme LLC
Phase 3
14,550
Cona, Rome, Bergamo, Brescia, Milan, Monza, Turin, Palermo
2023-10-09
Active, closed
AstraZeneca
Phase 3
5,511
Bergamo, Bologna, Florence, Genoa, Meldola, Milan, Misterbianco, Monza
2023-10-05
Recruiting
AstraZeneca
Phase 3
800
Bari, Bologna, Catania, Florence, Lecco, Milan, Monza, Naples
2023-09-22
Recruiting
Mesenchymal Stromal Cells for Traumatic Brain Injury
NCT06163833Traumatic Brain Injury With Loss of Consciousness
Fondazione IRCCS San Gerardo dei Tintori
Phase 2
78
Monza, Bergamo, Milan
2023-09-19
Recruiting
Hoffmann-La Roche
Phase 3
230
Meldola, Rome, Milan, Monza, Novara, Palermo, Bagno a Ripoli, Verona
2023-09-08
Recruiting
Gilead Sciences
Phase 3
402
Ancona, Castellana Grotte, Milan, Modena, Monza, Padova, Palermo, Pisa
2023-09-07
Active, closed
Enlighten Study: The EV-ICD Post Approval Registry
NCT06048731Ventricular Arrhythmia, Tachycardia
Medtronic
Observational
1,000
Bari, Bologna, Milan, Monza
2023-09-01
Recruiting
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
NCT06051409Ph+ ALL, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
DrugOlverembatinib
Ascentage Pharma Group Inc.
Phase 3
350
Bologna, Meldola, Milan, Monza, Ravenna, Roma, Torino, Varese
2023-08-31
Recruiting
Ipsen
Phase 3
276
Modena, Monza, Naples, Padova, Palermo, Pavia, Pisa, San Giovanni Rotondo
2023-08-31
Active, closed
Pfizer
Phase 3
59
Naples, Meldola, Monza
2023-08-09
Recruiting
Coping and Attachment in Pediatric Oncohematology
NCT06858163Pediatric Cancer, Coping Behavior, Relationship, Parent Child
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
60
Monza, Pavia, Taranto
2023-07-12
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
1,000
Salerno, Rome, Brescia, Milan, Baggiovara, Ponderano (Biella), Florence, Monza
2023-07-11
Active, closed
OncoC4, Inc.
Phase 3
630
Ancona, Bari, Bergamo, Catania, Milan, Monza, Naples, Palermo
2023-06-28
Recruiting
ModernaTX, Inc.
Observational
60
Naples, Monza, Florence
2023-06-16
Recruiting
Vancomycin in Primary Sclerosing Cholangitis in Italy
NCT05876182Primary Sclerosing Cholangitis, Liver and Intrahepatic Bile Duct Disorder, IBD
DrugVancomycin
University of Milano Bicocca
Phase 2
84
Monza
2023-06-15
Recruiting
Pfizer
Phase 2
100
Naples, Genoa, Monza, Rome, Catania, Padova, Pavia, Torino
2023-05-17
Recruiting
Takeda
Phase 3
240
Naples, Bologna, Rome, Monza, Florence, Padova
2023-05-16
Active, closed
Karyopharm Therapeutics Inc
Phase 3
257
Bologna, Brescia, Meldola, Milan, Monza, Naples, Padova, Pisa
2023-04-18
Recruiting
Eli Lilly and Company
Phase 1/2
880
Alessandria, Brescia, Milan, Monza, Pisa, Ravenna, Roma, Verona
2023-04-17
Recruiting
University of Milano Bicocca
Observational
10,000
Monza
2023-03-29
Recruiting
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase 2
60
Meldola, Monza, Pesaro, Bari, Bologna, Naples, Padova, Ravenna
2023-03-27
Active, closed
ELVN-002 in HER2 Mutant Non-Small Cell Lung Cancer
NCT05650879HER2 Mutant Non-small Cell Lung Cancer, HER2-positive Metastatic Breast Cancer, HER2 Gene Mutation, HER2 Amplification
DrugsELVN-002·Fam-Trastuzumab Deruxtecan-Nxki·Trastuzumab emtansine·Trastuzumab deruxtecan
Enliven Therapeutics
Phase 1
198
Monza, Candiolo, Aviano, Ancona, Roma, Rozzano
2023-03-20
Active, closed
Merck Sharp & Dohme LLC
Phase 2
129
Trieste, Monza, Palermo
2023-03-16
Active, closed
Insmed Incorporated
Phase 2/3
91
Pavia, Monza, Palermo, Roma
2023-03-07
Active, closed
Pfizer
Phase 3
624
Naples, Misterbianco, Bologna, Cona, Rome, Monza, Ancona, Pisa
2023-03-03
Recruiting
FDG-PET in the Diagnosis of Autoimmune Encephalitis
NCT06019975Autoimmune Encephalitis
University of Milano Bicocca
Observational
90
Udine, Genoa, Pavia, Milan, Monza
2023-03-01
Active, closed
Pfizer
Phase 1/2
20
Monza
2023-03-01
Active, closed
AlgoTherapeutix
Phase 2
276
Campobasso, Meldola, Milan, Monza, Pavia, Roma
2023-02-28
Active, closed
AriBio Co., Ltd.
Phase 3
1,535
Ancona, Brescia, Milan, Monza, Pisa, Roma, Torino, Tricase
2022-12-23
Active, closed
Dizal Pharmaceuticals
Phase 3
324
Aviano, Bologna, Catania, Florence, Grosseto, Meldola, Modena, Monza
2022-12-13
Active, closed
Celcuity Inc
Phase 3
701
Milan, Modena, Monza, Parma, Prato, Rome, Udine
2022-12-08
Active, closed
AbbVie
Phase 1
288
Milan, Monza
2022-12-05
Recruiting
Neurosurgical Outcome Network
NCT06724029Aneurysms, Arteriovenous Malformations, Cavernomas, Skull Base Tumors
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Observational
4,500
Bergamo, Brescia, Gravedona, Como, Cremona, Monza, Pavia, Sondrio
2022-12-05
Recruiting
Janssen Research & Development, LLC
Phase 2
520
Genova, Milan, Monza, Naples
2022-11-11
Recruiting
Pfizer
Phase 3
1,060
Meldola (Fc), Piacenza, Ravenna, San Giovanni Rotondo, Aviano, Monza, Turin, Palermo
2022-11-10
Active, closed
Genmab
Phase 1
17
Florence, Monza, Rome
2022-10-04
Recruiting
PedAL BCU, LLC
Phase 3
130
Genova, Monza, Roma, Torino
2022-10-01
Active, closed
Janssen Research & Development, LLC
Phase 2
577
Bari, Catania, Messina, Milan, Monserrato, Monza, Negrar, Palermo
2022-09-19
Active, closed
AstraZeneca
Phase 3
594
Aviano, Livorno, Meldola, Milan, Monza, Naples, Padova, Parma
2022-09-15
Recruiting
EPOS Discoid Meniscus (DiMe) Project
NCT05580315Discoid Meniscus of Knee
University of Milano Bicocca
Observational
500
Bergamo, Monza
2022-09-08
Recruiting
Stemline Therapeutics, Inc.
Phase 1/2
73
Ancona, Candiolo, Meldola, Messina, Milan, Modena, Monza, Naples
2022-08-31
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
410
Salerno, Rome, Baggiovara, Ponderano (Biella), Florence, Milan, Monza, Pisa
2022-08-23
Recruiting
IRCCS Burlo Garofolo
Observational
250
Monza, Roma, Torino, Trieste
2022-07-30
Active, closed
Gilead Sciences
Phase 3
443
Bari, Bologna, Brescia, Genova GE, Lecco, Lucca, Milan, Monza
2022-07-25
Active, closed
Janssen Research & Development, LLC
Phase 2
703
Bari, Catania, Messina, Milan, Monopoli, Monserrato, Monza, Negrar ( Ve)
2022-07-22
Active, closed
Gilead Sciences
Phase 3
623
Bari, Bologna, Brescia, Genova GE, Lecco, Lucca, Milan, Monza
2022-07-20
Active, closed
Incyte Corporation
Phase 1/2
53
Ravenna, Milan, Pavia, Monza, Candiolo, Pisa, Perugia
2022-07-19
Recruiting
Fondazione Italiana Linfomi - ETS
Phase 2
28
Ancona, Aviano, Florence, Miano, Monza, Naples, Roma, Palermo
2022-07-11
Recruiting
CardioPulmonary Resuscitation With Argon (CPAr) Trial
NCT05482945Cardiac Arrest, Out-Of-Hospital, Cardiac Arrest With Successful Resuscitation
Mario Negri Institute for Pharmacological Research
Phase 2
120
Genova, Monza, Milan, Parma, Pordenone, Reggio Emilia, Roma, Trento
2022-05-30
Recruiting
Electra Therapeutics Inc.
Phase 2/3
156
Florence, Genova, Milan, Monza, Padova, Roma, Trieste
2022-05-19
Recruiting
AstraZeneca
Phase 2
630
Aviano, Brescia, Catanzaro, Florence, Genova, Meldola, Milan, Monza
2022-04-14
Active, closed
Olorofim Aspergillus Infection Study
NCT05101187Invasive Aspergillosis
DrugAmbisome
F2G Biotech GmbH
Phase 3
225
Naples, Monza, Rozzano, Genova, Milan, Modena, Perugia, Pisa
2022-03-31
Active, closed
Sanofi
Phase 3
122
Bologna, Monza, Naples, Palermo, Roma
2022-03-11
Recruiting
Takeda
Phase 3
120
Naples, Bologna, Rome, Monza, Padova
2022-02-10
Recruiting
ARCAGY/ GINECO GROUP
Phase 2
390
Florence, Milan, Monza, Sondrio
2022-02-01
Recruiting
Novartis Pharmaceuticals
Phase 1/2
34
Genova, Monza, Roma, Torino
2021-12-27
Active, closed
Crizotinib Continuation Clinical Study
NCT05160922NSCLC, ALCL, IMT
DrugCrizotinib
Pfizer
Phase 4
27
Monza
2021-12-27
Active, closed
Merck Sharp & Dohme LLC
Phase 3
643
Bologna, Milan, Monza, Turin, Brescia
2021-12-13
Active, closed
Fondazione Italiana Linfomi - ETS
Phase 3
605
Meldola, Legnano, Sassuolo, Monza, Aviano, Pagani, Candiolo, Castelfranco Veneto
2021-12-01
Active, closed
AstraZeneca
Phase 3
454
Milan, Monza, Orbassano, Parma, Roma, Verona
2021-10-28
Recruiting
Pfizer
Phase 3
893
Meldola, Milan, Monza, Catania, Bologna, Genova, Roma
2021-10-04
Active, closed
Loxo Oncology, Inc.
Phase 3
282
Rionero in Vulture, Bergamo, Brescia, Meldola, Milan, Monza, Novara, Perugia
2021-09-23
Active, closed
Mirum Pharmaceuticals, Inc.
Phase 2
333
Ancona, Bergamo, Milan, Modena, Monza, Padova, Palermo, Pisa
2021-09-22
Active, closed
Sanofi
Phase 3
17
Monza
2021-09-01
Active, closed
MedSIR
Phase 2
393
Bologna, Milan, Monza, Parma, Piacenza, Roma
2021-08-05
Recruiting
University of Milano Bicocca
Observational
150
Monza
2021-07-31
Active, closed
Hoffmann-La Roche
Phase 3
142
Bari, Naples, Brescia, Monza, Turin
2021-06-25
Active, closed
Merck Sharp & Dohme LLC
Phase 3
342
Rome, Milan, Monza, Rozzano, Bari, Catania, Naples, Padova
2021-06-18
Active, closed
Sanofi
Observational
16
Monza, Florence
2021-06-10
Active, closed
Daiichi Sankyo
Phase 2
155
Bergamo, Bologna, Monza, Naples, Perugia
2021-06-03
Active, closed
Alectinib in Neo-adjuvant Treatment of Stage III NSCLC
NCT05015010Non Small Cell Lung Cancer
DrugAlectinib
Gruppo Oncologico Italiano di Ricerca Clinica
Phase 2
33
Meldola, Lido di Camaiore, Monza, Aviano, Orbassano, Bari, Bologna, Catania
2021-05-20
Recruiting
Merck Sharp & Dohme LLC
Phase 3
815
Monza, Milan, Rome, Naples
2021-05-12
Active, closed
Murdoch Childrens Research Institute
Not applicable
906
Monza, Varese, Florence, Milan, Rome
2021-05-04
Recruiting
University of Milano Bicocca
Observational
30
Monza
2021-04-15
Recruiting
POst-Prostatectomy Ablative Radiation Therapy
NCT04831970Radiation Toxicity
University of Milano Bicocca
Observational
30
Rozzano, Monza
2021-04-15
Active, closed
Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)
NCT04603495Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis
DrugsPelabresib·Ruxolitinib
Novartis Pharmaceuticals
Phase 3
430
Bergamo, Bologna, Brescia, Ferrara, Florence, Meldola, Milan, Monza
2021-04-09
Active, closed
Karyopharm Therapeutics Inc
Phase 3
353
Catania, Meldola, Genova, Milan, Monza, Novara, Rionero in Vulture, Roma
2021-03-11
Recruiting
AstraZeneca
Phase 1
304
Milan, Monza, Naples, Padova
2021-03-09
Recruiting
Syndax Pharmaceuticals
Phase 2
296
Brescia, Milan, Monza, Pavia, Roma, Torino
2021-03-04
Recruiting
Treosulfan Therapeutic Drug Monitoring in Pediatric Hematopoietic Stem Cell Transplant Recipients
NCT06861257Pediatric Hematopoietic Stem Cell Transplantation, Malignant Disorders, Non-malignant Disorders
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
70
Bologna, Brescia, Genova, Milan, Monza, Padova, Pavia, Torino
2021-02-24
Recruiting
SCAD : a Registry of Spontaneous Coronary Artery Dissection
NCT06601270Spontaneous Coronary Artery Dissection
European Society of Cardiology
Observational
1,500
Bergamo, Foggia, Genoa, Mantua, Milan, Monza
2021-01-30
Active, closed
Mirum Pharmaceuticals, Inc.
Phase 2
182
Bologna, Milan, Monza, Naples, Padova
2020-12-18
Active, closed
AstraZeneca
Phase 3
358
Bari, Florence, Monza, Orbassano, Padova, Rozzano, Varese
2020-12-16
Active, closed
GlaxoSmithKline
Phase 2/3
758
Ancona, Avellino, Florence, Milan, Monza, Naples, Orbassano to, Perugia
2020-12-08
Recruiting
Vyxeos® With Clofarabine for Pediatric AML
NCT07156435Relapsed Pediatric AML, Refractory Pediatric AML
DrugClofarabine
Princess Maxima Center for Pediatric Oncology
Phase 1
25
Monza, Roma
2020-11-06
Active, closed
Janssen Research & Development, LLC
Phase 3
308
Bologna, Catania, Meldola, Milan, Monza, Ravenna, Roma, Rozzano
2020-10-13
Active, closed
Hoffmann-La Roche
Phase 3
992
Meldola, Rome, Brescia, Milan, Monza, Misterbianco (CT), Candiolo, Livorno
2020-10-09
Active, closed
Janssen Research & Development, LLC
Phase 3
1,074
Avellino, Catania, Meldola, Milan, Monza, Naples, Orbassano, Ravenna
2020-09-30
Active, closed
Ipsen
Phase 3
161
Modena, Bologna, Milan, Monza, Padova, Palermo
2020-09-24
Active, closed
Daiichi Sankyo
Phase 1
145
Milan, Monza, Naples
2020-09-15
Active, closed
AbbVie
Phase 3
330
Bologna, Florence, Rome, Monza, Naples, Turin, Ancona, Bergamo
2020-08-31
Active, closed
Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery
NCT04498117Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Ovarian Cancer, Ovarian Serous Adenocarcinoma
DrugsOregovomab·Paraplatin·Taxol·Paclitaxel
CanariaBio Inc.
Phase 3
615
Rome, Monza
2020-08-25
Recruiting
Nordic Lymphoma Group
Phase 3
300
Aviano, Bari, Calabria, Monza, Naples, Roma, Segrate, Trieste
2020-08-19
Active, closed
GlaxoSmithKline
Phase 3
242
Milan, Modena, Monza, Naples, Negrar Verona, Padova, Palermo, Roma
2020-07-14
Active, closed
Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia
NCT04258943Philadelphia Chromosome Positive CML, Accelerated Phase Chronic Myelogenous Leukemia, Blastic Phase Chronic Myelogenous Leukemia, Chronic Phase Chronic Myelogenous Leukemia
DrugBosutinib
Children's Oncology Group
Phase 1/2
60
Monza, Rome, Torino
2020-07-06
Active, closed
Epizyme, Inc.
Phase 3
599
Naples, Meldola, Brescia, Catania, Florence, Lecce, Milan, Monza
2020-06-11
Recruiting
International CIPN Assessment and Validation Study
NCT04633655Chemotherapy-induced Peripheral Neuropathy, Quality of Life
University of Milano Bicocca
Observational
1,000
Monza, Como, Genova, Messina, Padova, Verona
2020-06-08
Active, closed
AstraZeneca
Phase 2
240
Bologna, Catanzaro, Meldola, Messina, Milan, Monza, Naples, Roma
2020-04-22
Active, closed
Fondazione Ricerca Traslazionale
Phase 2
206
Ponderano, Lecco, Catania, Grosseto, Province of Macerata, Monza, Modena, Piacenza
2020-03-02
Recruiting
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
NCT04294927BRCA1 Gene Mutation, BRCA2 Gene Mutation, RAD51C Gene Mutation, RAD51D Gene Mutation
University Medical Center Nijmegen
Not applicable
3,000
Bologna, Milan, Monza, Rome
2020-03-01
Recruiting
University of Milano Bicocca
Observational
1,433
Monza
2020-02-28
Active, closed
Eli Lilly and Company
Phase 3
261
Naples, Ravenna, Aviano, Rome, Monza, Milan, Rozzano, Orbassano
2020-02-17
Active, closed
Amicus Therapeutics
Phase 3
21
Monza
2020-02-13
Recruiting
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
NCT03934372Acute Myeloid Leukemia, Accelerated Phase Chronic Myeloid Leukemia, Blast Phase Chronic Myeloid Leukemia, Chronic Phase Chronic Myeloid Leukemia
DrugPonatinib
Incyte Biosciences International Sàrl
Phase 1/2
70
Bologna, Brescia, Genova, Milan, Monza, Naples, Pavia, Rome
2020-01-29
Recruiting
FATAL-NSTI Study (Factors Associated With In-hospital mortALity in NSTI).
NCT07359651Necrotizing Fascitis, Fournier Gangrene, Fournier's Gangrene, Soft Tissue Infections
University of Cagliari
Observational
300
Cagliari, Milan, Monza, Roma
2020-01-01
Active, closed
Gruppo Italiano Trapianto di Midollo Osseo
Phase 2
100
Brescia, San Giovanni Rotondo, Tricase, Monza, Ancona, Ascoli Piceno, Bari, Bologna
2019-12-09
Active, closed
Balt Extrusion
Observational
234
Milan, Monza, Treviso, Udine
2019-11-04
Active, closed
A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer
NCT04036682Non Small Cell Lung Cancer, EGFR Exon 20 Mutation
DrugZipalertinib
Cullinan Therapeutics Inc.
Phase 1/2
284
Careggi, Marche, Meldola, Milan, Modena, Monza, Ravenna
2019-10-31
By invitation
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
NCT03683186PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Hypertension
United Therapeutics
Phase 3
1,000
Palermo, Foggia, Genova, Milan, Monza, Pavia, Roma
2019-09-23
Active, closed
Janssen Research & Development, LLC
Phase 1
701
Milan, Monza, Naples, Ravenna
2019-09-04
Active, closed
Janssen Research & Development, LLC
Phase 2/3
118
Ascoli Piceno, Brescia, Catania, Florence, Milan, Monza, Novara, Roma
2019-08-15
Recruiting
Use of EBPT in Critically Ill Patients With AKI and/or Multiorgan Failure
NCT04033224Critical Illness, Acute Kidney Injury, Sepsis, Systemic Inflammatory Response Syndrome
Careggi Hospital
Observational
1,000
Empoli, Lido di Camaiore, Rozzano, San Donato Milanese, Monza, Brindisi, Florence, Pavia
2019-07-16
Active, closed
Eisai Inc.
Phase 3
1,906
Tricase, Cefalù, Genova, Milan, Monza, Naples, Perugia, Pisa
2019-03-27
Active, closed
Follow-up in Gynecological Cancer Survivors
NCT03515993Gynecologic Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Observational
1,100
Monza, Naples, Torino
2019-02-21
Recruiting
RECORDATI GROUP
Observational
95
Florence, Milan, Monza, Naples, Padova, Turin
2019-01-15
Active, closed
AstraZeneca
Phase 3
825
Ancona, Bari, Bergamo, Florence, Milan, Monza, Padova, Roma
2018-12-06
Active, closed
A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia
NCT03589326Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)
DrugsPonatinib·Imatinib·Cytarabine·Vincristine
Takeda
Phase 3
245
Meldola, Genoa, Monza, Reggio Emilia, Mestre, Bologna, Lecce, Milan
2018-10-04
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,500
Bologna, Rome, Milan, Monza, Rozzano, Aviano, Catania, Candiolo
2018-08-21
Active, closed
Daiichi Sankyo
Phase 1/2
65
Monza, Rome, Torino
2018-08-15
Recruiting
Celgene
Phase 2/3
1,541
Ancona, Bologna, Milan, Monza, Naples, Roma, Rome, Rozzano (MI)
2018-07-19
Active, closed
A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.
NCT03504397Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
DrugsZolbetuximab·Folinic acid·Fluorouracil·Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 3
565
Meldola, Monza, Vicenza, Ancona, Bergamo, Cremona, Milan, Modena
2018-06-21
Active, closed
Extended Access of Momelotinib in Adults With Myelofibrosis
NCT03441113Neoplasms, Post-polycythemia Vera Myelofibrosis (Post-PV MF), Primary Myelofibrosis (PMF), Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)
GlaxoSmithKline
Phase 2
237
Bologna, Florence, Genova, Milan, Monza, Naples, Pesaro, Rionero in Vulture PZ
2018-05-03
Active, closed
Centre Hospitalier Universitaire de Besancon
Not applicable
989
Milan, Monza
2018-05-03
Active, closed
Merck Sharp & Dohme LLC
Phase 3
797
Milano, Naples, Meldola, Rozzano, Milan, Monza, Orbassano, Brescia
2018-04-24
Active, closed
EBR Systems, Inc.
Not applicable
300
Bologna, Monza
2018-01-17
Active, closed
Hoffmann-La Roche
Phase 2/3
1,000
Naples, Meldola, Aviano, Rome, Bergamo, Cremona, Milan, Monza
2017-09-22
Active, closed
Hoffmann-La Roche
Phase 3
382
Naples, Modena, Rome, Genoa, Milan, Monza, Novara, Orbassano
2017-09-20
Active, closed
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
NCT03007147Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia, T Acute Lymphoblastic Leukemia
DrugsL-leucovorin·Therapeutic Hydrocortisone·Levofolinate·Isophosphamide
Children's Oncology Group
Phase 3
352
Monza
2017-08-08
Active, closed
Eli Lilly and Company
Phase 3
5,637
Naples, Cona, Meldola, Monza, Milan, Rozzano, Rome, Terni
2017-07-12
Active, closed
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
NCT03165734Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis
DrugPacritinib
Swedish Orphan Biovitrum
Phase 3
407
Bari, Bologna, Brescia, Florence, Forlì, Milan, Monza, Naples
2017-06-26
Active, closed
MedSIR
Phase 2
377
Bologna, Brindisi, Cremona, Mantua, Milan, Monza, Piacenza
2017-06-26
Active, closed
Pfizer
Phase 3
296
Catania, Monza, Milan, Rozzano, Perugia, Pordenone, Parma, Roma
2017-04-27
Active, closed
Novartis Pharmaceuticals
Phase 4
233
Bergamo, Bologna, Brescia, Meldola, Monza, Milan, Rozzano, Modena
2015-12-11
Recruiting
CAR-T Long Term Follow Up (LTFU) Study
NCT02445222Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program
Novartis Pharmaceuticals
Phase 3
1,105
Bologna, Monza, Milan, Rozzano, Roma
2015-11-02
Active, closed
Alliance Foundation Trials, LLC.
Phase 3
5,796
Ferrara, Florence, Genoa, Grosseto, Legnago, Meldola, Milan, Monza
2015-08
Active, closed
Taiho Oncology, Inc.
Phase 1/2
253
Bologna, Brescia, Milan, Monza
2015-07-14
Active, closed
Hoffmann-La Roche
Phase 3
154
Bari, Bologna, Meldola, Reggio Emilia, Milan, Monza, Pisa
2015-02-02
Recruiting
St. Anna Kinderkrebsforschung
Phase 2/3
1,800
Bologna, Florence, Genoa, Monza, Naples, Padova, Pavia, Pisa
2013-04
Active, closed
Apotransferrin in Atransferrinemia
NCT01797055Congenital Atransferrinemia
Prothya Biosolutions
Phase 2
5
Monza
2010-12
Active, closed
AstraZeneca
Phase 2
162
Genova, Milan, Monza, Torino
2010-02-04
Recruiting
Genzyme, a Sanofi Company
Observational
9,000
Florence, Milan, Baggiovara, Monza, Padua, Rome, Bassano del Grappa, Bologna
2001-07-31
Recruiting
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
NCT00358943Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease, Glucosylceramide Beta-Glucosidase Deficiency Disease
Genzyme, a Sanofi Company
Observational
12,000
Florence, Milan, Baggiovara, Monza, Rome, Sassari, Catania, Genova
1991-04-01
Rows per page Showing 1–277 of 277
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 October 2026. https://priyalifescience.com/clinical-trials-italy/city/monza

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 277 of those studies with a site in Monza.

How many clinical trials are recruiting in Monza?

165 of the 277 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 6 have not yet opened recruitment, 104 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Monza), 277 studies
PhaseStudiesRecruitingShare
Phase 31176142.2%
Observational534319.1%
Phase 2482817.3%
Not applicable18116.5%
Phase 1/217116.1%
Phase 2/31174%
Phase 11033.6%
Phase 4311.1%

Most active sponsors

Lead sponsors with the most studies (Monza)
Lead sponsorStudiesRecruiting
University of Milano Bicocca2320
AstraZeneca2113
Merck Sharp & Dohme LLC137
Eli Lilly and Company97
Janssen Research & Development, LLC93
Pfizer83
Daiichi Sankyo74
Hoffmann-La Roche61
Novartis Pharmaceuticals63
Sanofi62
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.